adhd cure latest news
| Health Calendar |
|---|
|
WednesdayVOLUNTEERS: North Carolina Baptist Hospital needs volunteers in patient and non-patient care service areas. Volunteer opportunities are available in the Brenner Children's Hospital, coronary care, the gift shop, transportation and way finders, the Cancer Center, and many other areas of the hospital. Training and orientation will begin at 5:30 p.m. |
| Coming Events |
|
An RAOB GLE Buffaloes group has formed locally and is looking for new and old members. Contact Jeff at 604-946-4794 for more information. |
| The Mystery of Stuttering |
|
A neurochemical glitch? |
| Coming up |
|
To add, remove or update a listing, e-mail editorial@thisweeknews.com. |
| Cognitive Behavioral Therapy Can Help With ADHD |
|
Both adults and kids can benefit. Here's how to find a good therapist. |
| KemPharm broadens protection for LAT prodrug technology platform for ADHD with second patent |
|
KemPharm, Inc. announced today that it has received a Notice of Issuance from the United States Patent and Trademark Office (USPTO) for its patent application entitled "Non-Standard Amino Acid Conjugates of Amphetamine and Processes for Making and Using the Same", U.S. Patent No. 7,776,917 B2. This patent, combined with KemPharm's recently issued U.S. Patent No. 7,772,222, provides broad ... |
| Traumatic brain injury causes $6.8 billion worth of economic trauma in Texas |
|
Each year in Texas, traumatic brain injury (TBI) causes an estimated $6.8 billion worth of economic trauma in terms of deaths, emergency room visits, hospitalizations and disability, according to a study commissioned by the CORE Health Foundation. To put that dollar amount in perspective, it equals Coca-Cola's corporate profit for fiscal 2009. |
| Health Buzz: FDA Issues Restaurant Calorie Count Guidelines |
|
Crash diets as a way to lose weight fast; cognitive behavioral therapy for ADHD. |
| It Really Is All in Your Head: Neurofeedback Can Change Your Brain |
|
It Really Is All in Your Head: Neurofeedback Can Change Your Brain |
| AMT's MAA for LPLD gene therapy product Glybera on schedule |
|
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today announced that the Marketing Authorisation Application (MAA) for Glybera(R) remains on schedule following meetings with the European Medicine Agency (EMA) concerning the Day 120 List of Questions. The company is confident that Glybera(R), a gene therapy product for lipoprotein lipase deficiency (LPLD), remains ... |